Details for New Drug Application (NDA): 087222
✉ Email this page to a colleague
NDA 087222 describes ANDROID 5, which is a drug marketed by Valeant Pharm Intl and is included in one NDA. Additional details are available on the ANDROID 5 profile page.
The generic ingredient in ANDROID 5 is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
The generic ingredient in ANDROID 5 is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
Summary for 087222
| Tradename: | ANDROID 5 |
| Applicant: | Valeant Pharm Intl |
| Ingredient: | methyltestosterone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087222
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;BUCCAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
